Cannabidiol for Refractory Childhood Epilepsy

We are studying whether adding CBD can help children with hard-to-treat epilepsy manage their seizures better. The trial also looks at how this treatment affects the quality of life for patients and their families.

1-2 years Confirmation phase (III)Post-Trial Drug Access Cost Reimbursement Partially Remote Standard Medicines OralNeurologyPediatrics

What diseases are being studied?

Health conditions and diseases that the clinical trial is designed to study and treat.

Who can participate in the clinical trial?

These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..

What active substances are being studied?

Active substances that are officially approved for use in the European Union and considered safe by EMA. These substances are already on the market and may be tested for new conditions or populations.

Cannabidiol

Cannabidiol is a substance that helps reduce seizures and relieve pain, anxiety, and inflammation.

Dronabinol

Dronabinol is a substance that reduces severe nausea from chemotherapy and helps stimulate appetite in people with AIDS-related weight loss.

Where is the clinical trial being conducted?

Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.

Loading map...

Universitair Medisch Centrum Utrecht

Pediatric Neurology

De Bilt, Netherlands

Epilepsy Instellingen Nederland Stichting

Pediatric Neurology

Heemstede, Netherlands

Kempenhaeghe

Pediatric Neurology

Heeze, Netherlands

Sponsor: Universitair Medisch Centrum Utrecht

Last updated: Nov 26, 2025

Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.